LAB.FARMACEUTICOS ROVI

24/05 CET
Closure
ISIN ES0157261019
Last:
19.1500
Dif:
0.6500
(3.51 %)
Volume:
4,779
1 Year Statistical Data
Data
Listed Days 255
IBEX Correlation (%) 4.27
Volatility [Y] 30.60
Alpha Ratio 0.06
Beta Ratio 0.40
Standard Deviation 1.60
Variance 2.57
Consolidated
2018-2 2017-4 Var.
Net Sales (MM€) 146.309 275.649 -46.92
P.B.T (MM€) 7.027 17.522 -59.92
Net Profit (MM€) 7.550 17.241 -56.20
Equity (MM€) 193.117 191.689 0.75
Reserves (MM€) 0.600 0.600 0.00
Amortization (MM€) -5.858 -11.479 -48.96
Net Profit/Sales (%) 5.160 6.255 -17.43
Sales per share (€) N.A. N.A. N,A,
C.Increase
Thursday
01
/Nov
2018
Type of capital increase: Con Prima
Percentage of the new securities that are issued: 99
Percentage of the old securities:
Price per share: 14.5
Unit nominal of the capital increase:
Rights trading: N
Nominal amount of the capital increase: 33,103
Unit price to be paid in the capital increase: 15
IPO date: 01/11/2018
Capital increase starting date: 01/11/2018
capital increase ending date: 01/11/2018
Economic rights: //
Capital increase in the year: 1
Tuesday
09
/Oct
2018
Type of capital increase: Con Prima
Percentage of the new securities that are issued: 11
Percentage of the old securities: 100
Price per share: 14.5
Unit nominal of the capital increase:
Rights trading: N
Nominal amount of the capital increase: 331,034
Unit price to be paid in the capital increase: 15
IPO date: 09/10/2018
Capital increase starting date: 09/10/2018
capital increase ending date: 09/10/2018
Economic rights: //
Capital increase in the year: 1